FLGT FULGENT GENETICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, FULGENT GENETICS INC reported revenue of $85.4M (up 4.4% from a year earlier), net income of −$29.5M and diluted EPS of n/a; over the last four quarters revenue was $324M and net income −$84.4M; for the fiscal year ended December 2025 revenue was $323M, up 13.8% on the year before.

FLGT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $323M, gross profit $131M, operating income −$91.1M, net income −$60.5M (margin -18.8%), EPS n/a
• Fiscal year ended Dec 2024: revenue $283M, gross profit $107M, operating income −$73.9M, net income −$42.7M (margin -15.1%), EPS n/a
• Fiscal year ended Dec 2023: revenue $289M, gross profit $104M, operating income −$196M, net income −$168M (margin -58.0%), EPS n/a
• Fiscal year ended Dec 2022: revenue $619M, gross profit $367M, operating income $179M, net income $143M (margin 23.2%), EPS n/a
• Fiscal year ended Dec 2021: revenue $993M, gross profit $777M, operating income $676M, net income $507M (margin 51.1%), EPS n/a

FLGT quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $85.4M (up 4.4% year over year), net income −$29.5M, EPS n/a
• Quarter ended Mar 31, 2026: revenue $71.1M (down 3.2% year over year), net income −$24.8M, EPS n/a
• Quarter ended Dec 31, 2025 (from the annual report): revenue $83.3M (up 9.3% year over year), net income −$23.4M, EPS n/a
• Quarter ended Sep 30, 2025: revenue $84.1M (up 17.2% year over year), net income −$6.61M, EPS n/a
• Quarter ended Jun 30, 2025: revenue $81.8M (up 15.2% year over year), net income −$19.0M, EPS n/a
• Quarter ended Mar 31, 2025: revenue $73.5M (up 13.9% year over year), net income −$11.5M, EPS n/a
• Quarter ended Dec 31, 2024 (from the annual report): revenue $76.2M (up 8.1% year over year), net income −$5.89M, EPS n/a
• Quarter ended Sep 30, 2024: revenue $71.7M (down 15.3% year over year), net income −$14.6M, EPS n/a
• Quarter ended Jun 30, 2024: revenue $71.0M (up 4.7% year over year), net income −$8.71M, EPS n/a
• Quarter ended Mar 31, 2024: revenue $64.5M (down 2.5% year over year), net income −$13.5M, EPS n/a
• Quarter ended Dec 31, 2023 (from the annual report): revenue $70.5M (up 4.1% year over year), net income −$128M, EPS n/a
• Quarter ended Sep 30, 2023: revenue $84.7M (down 19.8% year over year), net income −$13.1M, EPS n/a
• Quarter ended Jun 30, 2023: revenue $67.9M (down 45.9% year over year), net income −$11.2M, EPS n/a
• Quarter ended Mar 31, 2023: revenue $66.2M (down 79.3% year over year), net income −$15.3M, EPS n/a
• Quarter ended Dec 31, 2022: revenue $67.7M (down 73.1% year over year), net income −$23.8M, EPS n/a
• Quarter ended Sep 30, 2022: revenue $106M (down 53.6% year over year), net income $1.72M, EPS n/a
• Quarter ended Jun 30, 2022: revenue $125M (down 18.4% year over year), net income $11.5M, EPS n/a
• Quarter ended Mar 31, 2022: revenue $320M (down 10.9% year over year), net income $154M, EPS n/a
• Quarter ended Dec 31, 2021: revenue $252M, net income $104M, EPS n/a
• Quarter ended Sep 30, 2021: revenue $228M, net income $123M, EPS n/a

FLGT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$102M, share buybacks $10.9M
• Fiscal year ended Dec 2024: operating cash flow $21.1M, share buybacks $225K
• Fiscal year ended Dec 2023: operating cash flow $27.0M, share buybacks $25.1M
• Fiscal year ended Dec 2022: operating cash flow $254M, share buybacks $74.3M
• Fiscal year ended Dec 2021: operating cash flow $539M, share buybacks n/a

FLGT balance sheet

• Jun 30, 2026: cash $26.3M, total assets $1.09B, total liabilities $93.2M, shareholders' equity $1.00B
• Mar 31, 2026: cash $23.4M, total assets $1.16B, total liabilities $112M, shareholders' equity $1.05B
• Dec 31, 2025: cash $50.2M, total assets $1.21B, total liabilities $107M, shareholders' equity $1.11B
• Sep 30, 2025: cash $118M, total assets $1.21B, total liabilities $93.8M, shareholders' equity $1.13B
• Jun 30, 2025: cash $87.9M, total assets $1.20B, total liabilities $88.2M, shareholders' equity $1.12B
• Mar 31, 2025: cash $67.3M, total assets $1.21B, total liabilities $83.0M, shareholders' equity $1.13B
• Dec 31, 2024: cash $55.1M, total assets $1.22B, total liabilities $90.8M, shareholders' equity $1.13B
• Sep 30, 2024: cash $58.0M, total assets $1.23B, total liabilities $98.9M, shareholders' equity $1.14B

What is FLGT's revenue?

FULGENT GENETICS INC reported $324M of revenue over its last four quarters, through June 30, 2026.

Is FLGT profitable?

No. FULGENT GENETICS INC lost $84.4M over the last four quarters.

FLGT ownership and insider trades · All stocks